Overview
- 49 inspections across 47 sites are on record.
- 113 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-09-05.
At a glance
Inspections
49
Sites
47
Observations
113
Career since
May 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Livzon Group (Ningxia) Pharmaceutical Co., Ltd. | 5 Sep 2025 | Human Drugs | |
| Imprimis NJOF, LLC | 29 Jan 2021 | Human Drugs | On file |
| Validated Claim Support, LLC | 24 Aug 2020 | Human Drugs | |
| Aurolife Pharma LLC | 12 Feb 2020 | Human Drugs | On file |
| Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany | 20 Dec 2019 | Human Drugs | On file |
Sites inspected
Livzon Group (Ningxia) Pharmaceutical Co., Ltd.Shizuishan, China1 insp.
Imprimis NJOF, LLCLedgewood, United States1 insp.
Validated Claim Support, LLCTeaneck, United States1 insp.
Aurolife Pharma LLCDayton, United States1 insp.
Halo Pharmaceutical, Inc. d/b/a Cambrex WhippanyWhippany, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Guerlain Ulysse7 shared
Gianine E Tompkins6 shared
Jogy George5 shared
Lata C Mathew5 shared
Niketa Patel5 shared
Melissa T Roy3 shared
Nicholas A Violand2 shared
Zakaria I Ganiyu2 shared
Yvesna C Blaise2 shared
Melissa B Libby2 shared
Full investigator report
Get the verbatim findings behind Emmanuel J Ramos' 113 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site